Phase II trial of pyrazofurin in patients with multiple myeloma refractory to standard cytotoxic therapy

Cancer Treat Rep. 1979 Aug;63(8):1403-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / therapeutic use*
  • Drug Evaluation
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Ribonucleosides / administration & dosage
  • Ribonucleosides / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Ribonucleosides